The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 2-((4aR,5S,8aS)-4-(2-(3,4-Dichlorophenyl)acetyl)-5-(pyrrolidin-1-yl)octahydroquinoxalin-1(2H)-yl)acetate ID: ALA4072972
PubChem CID: 137632074
Max Phase: Preclinical
Molecular Formula: C23H31Cl2N3O3
Molecular Weight: 468.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)CN1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@@H]2[C@@H](N3CCCC3)CCC[C@@H]21
Standard InChI: InChI=1S/C23H31Cl2N3O3/c1-31-22(30)15-27-11-12-28(21(29)14-16-7-8-17(24)18(25)13-16)23-19(5-4-6-20(23)27)26-9-2-3-10-26/h7-8,13,19-20,23H,2-6,9-12,14-15H2,1H3/t19-,20-,23+/m0/s1
Standard InChI Key: MINYCOUUSMPSIG-SXWKCWPCSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
25.2300 -11.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5417 -12.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0343 -12.7759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2321 -12.5892 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.2070 -13.5801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5115 -14.0166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5422 -14.8411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2680 -15.2248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9676 -14.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6934 -15.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3930 -14.7353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3625 -13.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6324 -13.5273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9370 -13.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6006 -12.6988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2482 -12.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9620 -11.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1333 -11.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9076 -12.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7401 -10.7127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4291 -9.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6114 -9.8376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1056 -10.4942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4194 -11.2543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9311 -13.1331 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
25.9604 -15.6164 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
24.2970 -9.0704 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.2836 -10.3846 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.2976 -16.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5948 -16.4936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6246 -17.3222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8623 -16.1049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9217 -17.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 5 1 0
9 14 1 0
13 15 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
1 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 1 1 0
14 25 1 1
9 26 1 1
22 27 1 0
23 28 1 0
8 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
31 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.43Molecular Weight (Monoisotopic): 467.1742AlogP: 3.24#Rotatable Bonds: 5Polar Surface Area: 53.09Molecular Species: BASEHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.39CX LogP: 3.38CX LogD: 1.41Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.62Np Likeness Score: -0.75
References 1. Soeberdt M, Molenveld P, Storcken RP, Bouzanne des Mazery R, Sterk GJ, Autar R, Bolster MG, Wagner C, Aerts SN, van Holst FR, Wegert A, Tangherlini G, Frehland B, Schepmann D, Metze D, Lotts T, Knie U, Lin KY, Huang TY, Lai CC, Ständer S, Wünsch B, Abels C.. (2017) Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo., 60 (6): [PMID:28218838 ] [10.1021/acs.jmedchem.6b01868 ]